The Venture Codex Logo

The Venture Codex

Angelini Lumira Biosciences Fund

Rockville, MD, United States

Overview

Corporate venture capital fund focused on biosciences.

Founded

2021

Deals · 12mo

1

Stage focus

Seed
Series B

Geographic focus

United States

Sector focus

—

Investment portfolio

3rounds
NAMEDATESIZE
Navion Neurosciences
Sep 2026Led
$11 MSeed
Cadence Neuroscience
May 2023Led
$26 MSeries B
Navion Neurosciences
Oct 2021Led
$1 MSeed
Navion Neurosciences
Sep 2026Led
$11 MSeed
Cadence Neuroscience
May 2023Led
$26 MSeries B
Navion Neurosciences
Oct 2021Led
$1 MSeed
3
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Angelini Lumira Biosciences Fund: 3 funding rounds are recorded in the selected participation categories.All available history.
Angelini Lumira Biosciences Fund: 3 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed20
Series B10

Monthly Deal Activity

Angelini Lumira Biosciences Fund: 3 deals are recorded across 61 months.All available history.
Angelini Lumira Biosciences Fund: 3 deals are recorded across 61 months. All available history
MonthDeals
Oct '211
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '231
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '261
Oct '260

Sector Breakdown

Angelini Lumira Biosciences Fund: Health & Life Sciences is the largest displayed sector by deal count (3 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Angelini Lumira Biosciences Fund: Health & Life Sciences is the largest displayed sector by deal count (3 deals). All available history
SectorDeals
Health & Life Sciences3
Space & Frontier Tech3
AI & Machine Learning2

Deal Size Distribution

Angelini Lumira Biosciences Fund: 3 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Angelini Lumira Biosciences Fund: 3 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M1
$5M-$10M0
$10M-$25M1
$25M-$50M1
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Angelini Lumira Biosciences Fund: United States has the largest recorded deal count among the displayed regions (3 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Angelini Lumira Biosciences Fund: United States has the largest recorded deal count among the displayed regions (3 deals). All available history
RegionDeals
United States3
Angelini Lumira Biosciences Fund: 13 co-investors are shown, with 3B Future Health Fund sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Angelini Lumira Biosciences Fund: 13 co-investors are shown, with 3B Future Health Fund sharing 2 recorded deals. All available history
Co-investorShared deals
3B Future Health Fund2
Center for Innovative Technology2
Angelini Ventures1
F-Prime Capital1
JAZZ Venture Partners1
Kids Connect Charitable Fund1
LivaNova1
Mayo Clinic1
PDI Ventures1
Spectrum Financial Services1
UVA LVG Seed Fund1
UVA Seed Fund1
VTC Innovation Fund1

Investment Strategy

Angelini Lumira Biosciences Fund: Led accounts for 100% and participating for 0% of round participation.All available history.
Angelini Lumira Biosciences Fund: Led accounts for 100% and participating for 0% of round participation. All available history
CategoryDeals (count)Share (%)
Led3100%
Participating00%
Angelini Lumira Biosciences Fund: Single-lead accounts for 67% and co-led for 33% of lead dynamics.All available history.
Angelini Lumira Biosciences Fund: Single-lead accounts for 67% and co-led for 33% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead267%
Co-led133%

Team

Gerry Brunk

Managing Director